» Articles » PMID: 27654108

Impact of an In-visit Decision Aid on Patient Knowledge About Contralateral Prophylactic Mastectomy: A Pilot Study

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2016 Sep 23
PMID 27654108
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies have reported that breast cancer patients have limited understanding about the oncologic outcomes following contralateral prophylactic mastectomy (CPM). We hypothesized that an in-visit decision aid (DA) would be associated with higher patient knowledge about the anticipated short and long term outcomes of CPM.

Methods: We piloted a DA which used the SCOPED: (Situation, Choices, Objectives, People, Evaluation and Decision) framework. Knowledge, dichotomized as "low" (≤3 correct) versus "high" (≥4 correct), was assessed immediately after the visit by a 5 item survey. There were 97 DA patients (response rate 62.2 %) and 114 usual care (UC) patients (response rate 71.3 %).

Results: Patient demographic factors were similar between the two groups. Twenty-one (21.7 %) patients in the DA group underwent CPM compared with 18 (15.8 %) in the UC group (p = 0.22). Mean and median knowledge levels were significantly higher in the DA group compared with the UC group for patients of all ages, tumor stage, race, family history, anxiety levels, worry about CBC, and surgery type. Eighty-six (78.9 %) of UC versus 35 (37.9 %) DA patients had low knowledge. Of patients who underwent CPM, 15 (83.3 %) in the UC cohort versus 5 (25.0 %) of DA patients had "low" knowledge.

Conclusions: Knowledge was higher in the DA group. The UC group had approximately three times the number of patients of the DA group who were at risk for making a poorly informed decision to have CPM. Future studies should assess the impact of increased knowledge on overall CPM rates.

Citing Articles

The Incidence of Occult Malignancy in Contralateral Risk Reducing Mastectomy Among Affected Breast Cancer Gene Mutation Carriers in South Korea.

Lee C, Shin D, Kim K, Nam S, Kim S, Yu J J Breast Cancer. 2025; 28(1):1-10.

PMID: 40047086 PMC: 11885854. DOI: 10.4048/jbc.2024.0219.


Decision aids for people facing health treatment or screening decisions.

Stacey D, Lewis K, Smith M, Carley M, Volk R, Douglas E Cochrane Database Syst Rev. 2024; 1:CD001431.

PMID: 38284415 PMC: 10823577. DOI: 10.1002/14651858.CD001431.pub6.


Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer.

Wahlen M, Lizarraga I, Kahl A, Zahnd W, Eberth J, Overholser L Cancer Causes Control. 2023; 34(Suppl 1):171-186.

PMID: 37095280 PMC: 10689552. DOI: 10.1007/s10552-023-01689-9.


Computer-Based Decision Tools for Shared Therapeutic Decision-making in Oncology: Systematic Review.

Yung A, Kay J, Beale P, Gibson K, Shaw T JMIR Cancer. 2021; 7(4):e31616.

PMID: 34544680 PMC: 8579220. DOI: 10.2196/31616.


Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.

Lizarraga I, Schroeder M, Jatoi I, Sugg S, Trentham-Dietz A, Hoeth L Ann Surg Oncol. 2021; 28(13):8752-8765.

PMID: 34251554 PMC: 8595775. DOI: 10.1245/s10434-021-10426-y.